Ipragliflozin: a new drug for the treatment of type 2 diabetes mellitusL(U) Xin-ze, SUN Bo, YANG Wei, YU Fei, FU Sheng241-244
A management model of drug R&D projectXI Yan-bin, GU Xiao-hong, TANG Shi-huan, WU Tao, XIONG Wei245-249
Impact of governance structure in listed pharmaceutical companies on technological innovationCHEN Yu-ying, CHU Shu-zhen250-254
A cost analysis for two types of adjuvant anti-cancer therapy using an econometric modelGUAN Hai-jing, LIU Guo-en, WU Qiong, XIE Ji-pan, DU Xiao-yan, REN Xiao-xiao255-259
Quality control and evaluation of polysaccharide compositions in Chinese herbal medicinesZHANG Yong-wen260-263,280
Calibration of reference substances for melting pointLIU Yi, WU Jian-min, YAN Jing, WU Wei-bin, LIN Lan264-265,270
Construction of multiple copy secrete expression cassette for expression of hepatitis E virus ORF2128-660 in Pichia pastorisGUO Min, LEI Qing, LIU Xiao, JIANG Lin271-275,302
Advantages of traditional Chinese medicine in treating myocardial no-reflow after acute myocardial infarction/reperfusionZHANG Jin-yan, LI Shao-chun, LI Yi-kui, ZHAO Le, WENG Wei-liang, LI Lian-da276-280
Progress in small-molecule targeted therapy for the treatment of melanomaSHEN Fu-wen, YE Li, LIU Jing-ge, ZHU Yong-liang, TAO Min, QIAN Xiang-ping281-287